Product NDC: | 62756-437 |
Proprietary Name: | NARATRIPTAN HYDROCHLORIDE |
Non Proprietary Name: | NARATRIPTAN HYDROCHLORIDE |
Active Ingredient(s): | 2.5 mg/1 & nbsp; NARATRIPTAN HYDROCHLORIDE |
Administration Route(s): | ORAL |
Dosage Form(s): | TABLET, FILM COATED |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 62756-437 |
Labeler Name: | Sun Pharmaceutical Industries Limited |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA091552 |
Marketing Category: | ANDA |
Start Marketing Date: | 20110222 |
Package NDC: | 62756-437-88 |
Package Description: | 100 TABLET, FILM COATED in 1 BOTTLE (62756-437-88) |
NDC Code | 62756-437-88 |
Proprietary Name | NARATRIPTAN HYDROCHLORIDE |
Package Description | 100 TABLET, FILM COATED in 1 BOTTLE (62756-437-88) |
Product NDC | 62756-437 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | NARATRIPTAN HYDROCHLORIDE |
Dosage Form Name | TABLET, FILM COATED |
Route Name | ORAL |
Start Marketing Date | 20110222 |
Marketing Category Name | ANDA |
Labeler Name | Sun Pharmaceutical Industries Limited |
Substance Name | NARATRIPTAN HYDROCHLORIDE |
Strength Number | 2.5 |
Strength Unit | mg/1 |
Pharmaceutical Classes | Serotonin 1b Receptor Agonists [MoA],Serotonin 1d Receptor Agonists [MoA],Serotonin-1b and Serotonin-1d Receptor Agonist [EPC] |